🇺🇸 FDA

Company profile · Sponsor

Pacira

Pacira Ireland Limited

PCRX · NYSE pharma BRISBANE, CA, GB
Pipeline
24
Drugs
3
Patents
8

Quick answer

Pacira (PCRX) is a pharma company. headquartered in BRISBANE, CA, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 3 drugs, and 8 patents to this profile..

Company facts

Ticker PCRX
Exchange NYSE
Company type pharma
Headquarters BRISBANE, CA, GB
SEC CIK 0001396814

Pipeline (24)

Search pipeline →

  1. Bupivacaine

    Pacira

    Malignant Neoplasms of Female Genital Organs

    phase 3 small molecule terminated

    1 trial

  2. Bupivacaine HCl

    Pacira

    Hemorrhoids

    phase 3 small molecule completed

    1 trial

  3. Bupivacaine HCl

    Pacira

    Postoperative Pain

    phase 3 small molecule completed

    3 trials

  4. Bupivacaine liposome

    Pacira

    Dental Pain

    phase 3 small molecule completed

    1 trial

  5. Bupivacaine liposome injectable suspension 266 mg

    Pacira

    Bunionectomy

    phase 3 small molecule completed

    1 trial

  6. Cryo-Touch II

    Pacira

    Facial Wrinkles

    phase 3 other completed

    2 trials

  7. Cryo-Touch III

    Pacira

    Facial Wrinkles

    phase 3 other completed

    1 trial

  8. Duloxetine

    Pacira

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial

  9. EXPAREL

    Pacira

    Total Ankle Arthroplasty

    phase 3 small molecule active

    1 trial

  10. EXPAREL 13.3Mg/mL Suspension for Injection

    Pacira

    Bunion

    phase 3 small molecule terminated

    1 trial

  11. EXPAREL 266 mg

    Pacira

    Posterolateral Thoracotomy

    phase 3 small molecule completed

    1 trial

  12. Exparel

    Pacira

    Lower Extremity Surgery

    phase 3 small molecule completed

    1 trial

  13. Exparel

    Pacira

    Chronic Shoulder Pain

    phase 3 small molecule active

    1 trial

  14. Exparel

    Pacira

    Mammaplasty

    phase 3 small molecule completed

    1 trial

  15. Exparel

    Pacira

    Back Pain

    phase 3 small molecule active

    1 trial

  16. Exparel

    Pacira

    Postoperative Pain Management

    phase 3 small molecule completed

    3 trials

  17. Exparel Injectable Product

    Pacira

    Coronary Artery Disease

    phase 3 small molecule completed

    1 trial

  18. FX006

    Pacira

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    2 trials

  19. FX006

    Pacira

    Osteoarthritis, Hip

    phase 3 small molecule terminated

    1 trial

  20. FX006 32 mg

    Pacira

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial

  21. FX006 32 mg

    Pacira

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    4 trials

  22. Liposomal bupivacaine

    Pacira

    Surgery

    phase 3 small molecule completed

    1 trial

  23. Placebo

    Pacira

    Postoperative Pain

    phase 3 small molecule completed

    1 trial

  24. SKY0402

    Pacira

    Bunion

    phase 3 small molecule completed

    1 trial

Drugs (3)

Search drugs →

  1. bupivacaine

    EXPAREL LIPOSOMAL

    PERIARTICULAR approved

    N01BB01

  2. cytarabine

    DEPOCYTE

    INJECTION approved

    L01BC01

  3. morphine sulfate

    MORPHINE SULFATE

    INTRAMUSCULAR approved

Patents (8)

Search patents →

  1. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12364764

    Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12318483

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12296047

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12285435

    Multivesicular liposome formulations of dexamethasone

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12285419

    Bupivacaine multivesicular liposome formulations and uses thereof

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12280149

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Pacira?

Pacira (PCRX) is a pharma company. headquartered in BRISBANE, CA, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 3 drugs, and 8 patents to this profile..

What pipeline programs does Pacira sponsor?

We track 24 ClinicalTrials.gov-linked programs for Pacira, including Bupivacaine and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Pacira company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.